1 / 4

China Carbon Fiber Market Size, Industry Trends, Share and Forecast 2020-2026

The preventive inhaler market in the Asia-Pacific region presents future opportunities for growth as the prevalence of respiratory diseases such as asthma, COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growing market for preventive inhalers.

larebomrglobal
Download Presentation

China Carbon Fiber Market Size, Industry Trends, Share and Forecast 2020-2026

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Asia-Pacific Preventive Inhaler Market:Industry Growth, Size, Share and Forecast 2019-2025 Request https://www.omrglobal.com/request-sample/asia-pacific-preventive-inhaler-market -------------------------------------------------------------------------------------------------------------------------------------------------- Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780304040 a Free Sample of Report Asia-Pacific Preventive Inhaler Market at

  2. Asia-Pacific preventive inhaler market is anticipated to grow at a substantial growth rate of around 3.8% during the forecast period. Major factors that augments the growth of the market include large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and significant presence of market players in the region. Asia-Pacific has a potential market due to the increasing R&D and investments by big pharmaceutical companies in life science research coupled with harnessing innovation. The preventive inhaler market in the Asia-Pacific region presents future opportunities for growth as the prevalence of respiratory diseases such as asthma, COPD in emerging economies such as India and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growing market for preventive inhalers. A full Report of Asia-Pacific Preventive Inhaler Market at https://www.omrglobal.com/industry- reports/asia-pacific-preventive-inhaler-market The Asia-Pacific preventive inhaler market is segmented on the basis of device type, application, and end-user. On the basis of device type, the market is sub-segmented into the metered dosed inhaler and dry powdered inhaler. The dry powder inhaler is estimated to have the largest market share in the Asia-Pacific preventive inhaler market due to providing an easy inhalation solution. Moreover, on the basis of application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/asia-pacific-preventive-inhaler-market Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing preventive inhalers to cater to a wide range of customers within the region and across the globe. The major players of the Asia-Pacific preventive inhaler market include 3M Co., AstraZeneca PLC, Aradigm Corp., Adherium Ltd., GlaxoSmithKline PLC, Novartis AG, Propeller Health, Teva Pharmaceuticals Industries Ltd. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players. For instance, in May 2018, the company established a partnership with MannKind for marketing and distributing Afrezza. It is the only US FDA approved inhaled insulin available for patients suffering from diabetes. In addition, the company in February 2018, has entered into a partnership with Roche Pharma India for healthcare improvement and increasing access to life-changing medicines in India. Asia-Pacific Preventive Inhaler Market Segmentation By Device Type •Metered Dose Inhaler •Dry Powder Inhaler

  3. By Application •Asthma •Chronic Obstructive Pulmonary Disease (COPD) •Asia-Pacific Preventive Inhaler Market by End-User •Homecare •Hospitals and Clinics Regional Analysis •China •Japan •India •Rest of Asia-Pacific Company Profiles •3M Co. •Acorda Therapeutics, Inc. •Adamis Pharmaceuticals Corp. •Adherium Ltd. •Aradigm Corp. •AstraZeneca PLC •Beximo Pharmaceuticals Ltd. •Boehringer Ingelheim International GmbH •Cipla Ltd. •GlaxoSmithKline PLC •Koninklijke Philips N.V. •MidasCare Pharmaceutical Pvt. Ltd. •Novartis AG •Omron Healthcare Inc. •ResMed Corp. •Sunovion Pharmaceuticals •Teijin Pharma Ltd. •Teva Pharmaceuticals Industries Ltd. For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report- customization/asia-pacific-preventive-inhaler-market

  4. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. AnuragTiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 780-304-0404

More Related